In an increasingly capital-constrained and compliance-driven environment, finance and accounting leaders in biopharma are being called upon to deliver more precision, speed, and strategic insight, often with limited resources. This mid-year outlook survey captures the priorities, pain points, and emerging practices shaping today’s financial operations across clinical-stage companies.
